Forsyth S F, Guilford W G, Haslett S J, Godfrey J
Department of Veterinary Clinical Sciences, Massey University, Palmerston North, New Zealand.
J Small Anim Pract. 1998 Sep;39(9):421-4. doi: 10.1111/j.1748-5827.1998.tb03748.x.
Endoscopy was undertaken to examine the gastroduodenal mucosa of 24 healthy dogs after seven days and again after 28 days of oral non-steroidal anti-inflammatory drug (NSAID) administration. The dogs were divided into four groups. One group received ketoprofen (1 mg/kg every 24 hours), one group carprofen (2 mg/kg every 12 hours for seven days followed by 2 mg/kg every 24 hours), a third group meloxicam suspension (0.2 mg/kg every 24 hours), and the last group gelatin (one capsule every 24 hours). Serum biochemical and complete blood count parameters did not change significantly after NSAID administration. Gastroduodenal lesions were observed in 17 dogs, but in all cases these were mild to moderate. The dogs receiving gelatin or carprofen showed the fewest and the least severe lesions, although there was no statistically significant difference between the three test drugs and the control group (P < or = 0.05). None of the dogs showed any clinical signs related to the gastrointestinal lesions.
在内服非甾体抗炎药(NSAID)7天后及28天后,对24只健康犬的胃十二指肠黏膜进行了内镜检查。这些犬被分为四组。一组接受酮洛芬(每24小时1毫克/千克),一组接受卡洛芬(前7天每12小时2毫克/千克,之后每24小时2毫克/千克),第三组接受美洛昔康混悬液(每24小时0.2毫克/千克),最后一组接受明胶(每24小时1粒胶囊)。服用NSAID后,血清生化指标和全血细胞计数参数无显著变化。在17只犬中观察到胃十二指肠病变,但所有病例均为轻度至中度。接受明胶或卡洛芬的犬病变最少且最轻微,尽管三种受试药物与对照组之间无统计学显著差异(P≤0.05)。没有一只犬表现出与胃肠道病变相关的任何临床症状。